semaglutide elizabeth Ozempic’s potential as alcoholism cure is focus of new study Back for the sixth and

Early data show benefits of glucagon-like peptide-1 receptor agonists in halting the progression of this progressive neurologic disorder, which stems from a dopamine deficiency

Our specialized testing solutions support pharmaceutical companies with accurate evaluation of identification, assay by HPLC, potency, purity, biological activity, sterility, and BET analysis

Behind the trend is the surging popularity of GLP-1 weight loss medications, a class of so-called peptides approved to help users quickly shed pounds.

Ron Grisanti, D.C., D.A.B.C.O., D.A.C.B.N., M.S., DIANM, CFMP is the founder of Functional Medicine University and author of The Medical Detective Reports. Read his full bio ...

Strong evidence supports their efficacy in inducing clinically meaningful weight loss in individuals with overweight or obesity